UnknownNot Applicable

Infectious Mediastinitis Among the Strasbourg Universitary Hospital

France100 participantsStarted 2021-06-01

Plain-language summary

Mediastinitis are rare but serious infections, with mortality rates varying from 6 to 30% according to the literature. They are essentially linked to surgical management (cardio-thoracic in particular), but some forms can be spontaneous, after extension of an ENT infectious focus, for example. Despite their seriousness, there is no strong recommendations to define their management, especially concerning antibiotic therapy and its duration. The aim of this research is to make a descriptive analysis of the cases of mediastinitis at HUS in recent years, and to study the therapeutic strategy used

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Major subject (≥18 years old) * Subject diagnosed with mediastinitis between 01/01/2010 and 31/12/2020 * Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research. Exclusion Criteria: * Subject having expressed opposition to participate in the study * Subject under guardianship, curatorship or safeguard of justice

What they're measuring

Analysis of the cases of mediastinitis and the therapeutic strategy used in recent years at University Hospitals of Strasbourg

Timeframe: Files analysed retrospectively from January 01, 2010 to December 31, 2020 will be examined]

Trial details

NCT IDNCT05001308

SponsorUniversity Hospital, Strasbourg, France

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-05

Contact for this trial

Yvon RUCH, MD

33 3 69 55 12 19 yvon.ruch@chru-strasbourg.fr

View on ClinicalTrials.gov More Mediastinitis trials